Development and prospective validation of an estrogen receptor positive breast cancer risk model to identify women who could benefit for risk-reducing therapies

被引：0
|
作者：
Ahearn, Thomas U.
Mukhopadhyay, Srijon
Balasubramanian, Jeya
Chatterjee, Nilanjan
Garcia-Closas, Montserrat
Choudhury, Parichoy Pal
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3464
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer
    Jayasekera, Jinani
    Zhao, Amy
    Schechter, Clyde
    Lowry, Kathryn
    Yeh, Jennifer M.
    Schwartz, Marc D.
    O'Neill, Suzanne
    Wernli, Karen J.
    Stout, Natasha
    Mandelblatt, Jeanne
    Kurian, Allison W.
    Isaacs, Claudine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (04) : 859 - +
  • [2] Could your patient benefit from a breast CA risk-reducing med?
    Campos-Outcalt, Doug
    JOURNAL OF FAMILY PRACTICE, 2019, 68 (10):
  • [3] Risk-reducing Surgery in Women at Risk for Familial Breast or Ovarian Cancer
    Rhiem, K.
    Pfeifer, K.
    Schmutzler, R. K.
    Kiechle, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (09) : 833 - 839
  • [4] Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery
    Irelli, Azzurra
    Patruno, Leonardo Valerio
    Ranieri, Sofia Chiatamone
    Di Giacomo, Daniela
    Malatesta, Sara
    Alesse, Edoardo
    Tessitore, Alessandra
    Cannita, Katia
    BIOMEDICINES, 2024, 12 (04)
  • [5] Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition
    Jatoi, Ismail
    EUROPEAN JOURNAL OF BREAST HEALTH, 2018, 14 (04) : 189 - 193
  • [6] Development of risk prediction models for estrogen receptor-positive breast cancer in Japanese women
    Yamashita, Hiroko
    Iwase, Hirotaka
    Yoshimoto, Nobuyasu
    Baba, Motoi
    Ishida, Naoko
    Toyama, Tatsuya
    Tamakoshi, Akiko
    CANCER SCIENCE, 2018, 109 : 772 - 772
  • [7] The role of endocrine therapies in reducing risk of recurrence in postmenopausal women with hormone receptor-positive breast cancer
    Pennery, Emma
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2008, 12 (03) : 233 - 243
  • [8] Can we identify women at risk for receptor (ER) positive breast cancer
    Gorla, SR
    Hou, N
    Acharya, S
    Rademaker, AW
    Staradub, V
    Khan, SA
    Morrow, M
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S99 - S99
  • [9] Can we identify women at risk for receptor (ER) positive breast cancer
    S. R. Gorla
    N. Hou
    S. Acharya
    A. W. Rademaker
    V. Staradub
    S. A. Khan
    M. Morrow
    Annals of Surgical Oncology, 2004, 11 : S99 - S99
  • [10] Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series
    Ricciardi, Enzo
    Tomao, Federica
    Aletti, Giovanni
    Bazzurini, Luca
    Bocciolone, Luca
    Boveri, Sara
    Landoni, Fabio
    Lapresa, Maria Teresa
    Maruccio, Matteo
    Parma, Gabriella
    Peccatori, Fedro
    Petrella, Maria Cristina
    Zanagnolo, Vanna
    Colombo, Nicoletta
    Maggioni, Angelo
    ANTICANCER RESEARCH, 2017, 37 (09) : 5241 - 5248
12345